Last 7 days
-0.4%
Last 30 days
-7.3%
Last 90 days
-16.6%
Trailing 12 Months
12.4%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-11 | Munch Mark | sold (taxes) | -105,663 | 66.96 | -1,578 | exec vp&pres bruker nano inc. |
2023-08-11 | Herman Gerald N | sold (taxes) | -61,134 | 66.96 | -913 | executive vice president, cfo |
2023-08-11 | LAUKIEN FRANK H | sold (taxes) | -296,030 | 66.96 | -4,421 | president & ceo |
2023-08-10 | Srega Juergen | acquired | - | - | 14,695 | president calid |
2023-08-10 | Busse Falko | acquired | - | - | 4,526 | president, biospin group |
2023-08-10 | Prause Burkhard | acquired | - | - | 2,371 | pres. & ceo, bruker best |
2023-08-10 | Munch Mark | acquired | - | - | 12,410 | exec vp&pres bruker nano inc. |
2023-08-10 | Herman Gerald N | acquired | - | - | 12,168 | executive vice president, cfo |
2023-08-10 | LAUKIEN FRANK H | acquired | - | - | 38,521 | president & ceo |
2023-08-09 | Munch Mark | sold (taxes) | -140,621 | 65.68 | -2,141 | exec vp&pres bruker nano inc. |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-26 | BROOKFIELD Corp /ON/ | reduced | -59.56 | -9,535,360 | 5,824,010 | 0.02% |
2023-09-20 | BARCLAYS PLC | added | 228 | 3,367,000 | 4,988,000 | -% |
2023-09-12 | Farther Finance Advisors, LLC | added | 90.37 | 11,576 | 26,325 | 0.01% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | unchanged | - | -334 | 5,027 | -% |
2023-09-05 | Covenant Partners, LLC | new | - | 275,204 | 275,204 | 0.10% |
2023-09-01 | Portside Wealth Group, LLC | new | - | 296,198 | 296,198 | 0.06% |
2023-08-22 | COMERICA BANK | new | - | 10,000 | 10,000 | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | reduced | -35.6 | -1,009,000 | 1,537,540 | 0.01% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 10.43 | 44,000 | 1,298,000 | 0.01% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -3.49 | -979,755 | 9,315,250 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | t. rowe price investment management, inc. | 11.1% | 16,368,144 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 7.51% | 11,045,016 | SC 13G/A | |
Feb 08, 2023 | massachusetts financial services co /ma/ | 5.1% | 7,513,039 | SC 13G | |
Jan 31, 2023 | blackrock inc. | 7.6% | 11,118,621 | SC 13G/A | |
Jan 23, 2023 | laukien joerg c | 5.1% | 7,515,769 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 13.7% | 20,854,627 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 7.10% | 10,765,626 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 04, 2022 | blackrock inc. | 7.2% | 10,844,554 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Oct 03, 2023 | 3 | Insider Trading | |
Oct 03, 2023 | 4 | Insider Trading | |
Sep 29, 2023 | SC TO-T/A | SC TO-T/A | |
Sep 20, 2023 | SC TO-T/A | SC TO-T/A | |
Aug 31, 2023 | SC TO-T | SC TO-T | |
Aug 17, 2023 | SC TO-C | SC TO-C | |
Aug 14, 2023 | 4 | Insider Trading | |
Aug 14, 2023 | 4 | Insider Trading | |
Aug 14, 2023 | 4 | Insider Trading | |
Aug 14, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
TMO | 192.8B | 43.5B | -10.34% | -4.46% | 33.68 | 4.43 | 1.64% | -23.14% |
A | 32.3B | 7.0B | -9.56% | -12.76% | 28.51 | 4.62 | 5.03% | -14.68% |
MTD | 23.5B | 4.0B | -11.99% | -5.07% | 26.47 | 5.95 | 2.30% | 16.37% |
ILMN | 21.2B | 4.5B | -20.50% | -28.48% | -5.05 | 4.74 | -4.92% | -21931.58% |
BRKR | 9.0B | 2.7B | -7.34% | 12.40% | 28.11 | 3.3 | 9.64% | 16.50% |
MID-CAP | ||||||||
NEO | 1.5B | 551.6M | -23.10% | 33.93% | -12.93 | 2.69 | 12.73% | 21.90% |
SMALL-CAP | ||||||||
PACB | 2.0B | 146.1M | -31.29% | 34.48% | -6.15 | 13.44 | 4.72% | -55.19% |
QTRX | 1.0B | 112.0M | -0.85% | 155.15% | -15.26 | 8.97 | 0.83% | 16.42% |
ADPT | 755.0M | 189.6M | -23.35% | -28.00% | -3.95 | 3.98 | 18.74% | 17.75% |
EYPT | 275.5M | 37.3M | -23.67% | 12.62% | -2.6 | 7.38 | -9.96% | -38.49% |
HBIO | 182.7M | 114.1M | -2.95% | 61.51% | -33.65 | 1.6 | -5.49% | -48.58% |
CDXS | 138.9M | 99.2M | 10.56% | -67.22% | -2.45 | 1.4 | -26.56% | -199.52% |
CDXC | 107.8M | 80.9M | -7.69% | 9.09% | -16.6 | 1.33 | 17.20% | 77.07% |
BNGO | 95.4M | 31.5M | -25.45% | 59.44% | -0.65 | 3.03 | 35.12% | -38.47% |
11.7%
15.9%
13.2%
16.5%
73.5%
37.7%
5.4%
Y-axis is the maximum loss one would have experienced if Bruker was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 3.6% | 2,715 | 2,621 | 2,531 | 2,506 | 2,476 | 2,458 | 2,418 | 2,362 | 2,264 | 2,118 | 1,988 | 1,960 | 1,970 | 2,035 | 2,073 | 2,026 | 1,972 | 1,925 | 1,896 | 1,873 | 1,842 |
Cost Of Revenue | 4.1% | 1,313 | 1,262 | 1,225 | 1,224 | 1,221 | 1,221 | 1,208 | 1,181 | 1,144 | 1,092 | 1,048 | 1,037 | 1,041 | 1,062 | 1,077 | 1,055 | 1,031 | 1,010 | 996 | 989 | 982 |
Gross Profit | 3.1% | 1,401 | 1,359 | 1,306 | 1,281 | 1,255 | 1,237 | 1,210 | 1,181 | 1,121 | 1,026 | 940 | 923 | 929 | 973 | 995 | 972 | 941 | 915 | 900 | 883 | 860 |
Operating Expenses | 3.3% | 930 | 900 | 873 | 854 | 846 | 817 | 796 | 780 | 752 | 705 | 692 | 670 | 669 | 698 | 694 | 682 | 670 | 649 | 638 | 632 | 626 |
S&GA Expenses | 4.1% | 650 | 624 | 607 | 596 | 593 | 575 | 561 | 538 | 512 | 479 | 469 | 469 | 479 | 501 | 500 | 487 | 468 | 455 | 445 | 439 | 436 |
R&D Expenses | 4.6% | 260 | 248 | 236 | 231 | 226 | 223 | 221 | 220 | 216 | 204 | 198 | 188 | 185 | 190 | 188 | 186 | 182 | 177 | 173 | 172 | 171 |
EBITDA | -100.0% | - | 543 | 527 | 500 | 480 | 505 | 497 | - | - | 396 | 321 | 324 | 331 | 347 | 372 | 356 | 335 | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.21* | 0.21* | 0.20* | 0.19* | 0.21* | 0.21* | - | - | 0.19* | 0.16* | 0.17* | 0.17* | 0.17* | 0.18* | 0.18* | 0.17* | - | - | - | - |
Interest Expenses | - | - | - | 24.00 | - | - | - | 20.00 | - | - | - | 29.00 | - | - | - | 16.00 | - | - | - | 12.00 | - | - |
Earnings Before Taxes | 1.9% | 434 | 427 | 414 | 412 | 392 | 402 | 394 | 380 | 346 | 298 | 226 | 231 | 239 | 256 | 280 | 269 | 252 | 247 | 245 | 233 | 215 |
EBT Margin | -100.0% | - | 0.16* | 0.16* | 0.16* | 0.16* | 0.16* | 0.16* | 0.16* | 0.15* | 0.14* | 0.11* | 0.12* | 0.12* | 0.13* | 0.14* | - | - | - | - | - | - |
Net Income | 2.4% | 319 | 312 | 297 | 275 | 274 | 282 | 277 | 270 | 238 | 204 | 158 | 158 | 165 | 177 | 197 | 207 | 189 | 184 | 180 | 98.00 | 92.00 |
Net Income Margin | -100.0% | - | 0.12* | 0.12* | 0.11* | 0.11* | 0.11* | 0.11* | 0.11* | 0.10* | 0.10* | 0.08* | 0.08* | 0.08* | 0.09* | 0.10* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 149 | 145 | 119 | 114 | 176 | 190 | 254 | 312 | 304 | 235 | 169 | 140 | 141 | 140 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 2.5% | 3,857 | 3,764 | 3,612 | 3,337 | 3,385 | 3,551 | 3,650 | 3,128 | 3,087 | 3,035 | 3,049 | 2,879 | 2,943 | 2,962 | 2,772 | 2,352 | 2,350 | 2,243 | 2,129 | 1,889 | 1,806 |
Current Assets | 2.4% | 2,183 | 2,133 | 2,113 | 2,037 | 2,088 | 2,251 | 2,472 | 1,989 | 1,968 | 1,946 | 1,925 | 1,826 | 1,957 | 1,990 | 1,796 | 1,434 | 1,406 | 1,344 | 1,304 | 1,262 | 1,182 |
Cash Equivalents | -3.9% | 575 | 598 | 646 | 626 | 726 | 820 | 1,072 | 577 | 612 | 700 | 686 | 571 | 750 | 799 | 682 | 300 | 287 | 303 | 326 | 275 | 263 |
Inventory | 6.5% | 915 | 859 | 800 | 750 | 759 | 740 | 710 | 733 | 730 | 701 | 692 | 696 | 665 | 626 | 577 | 587 | 595 | 542 | 510 | 519 | 509 |
Net PPE | 2.3% | 523 | 511 | 487 | 422 | 395 | 404 | 406 | 389 | 398 | 384 | 396 | 355 | 336 | 319 | 306 | 278 | 282 | 268 | 271 | 261 | 259 |
Goodwill | 5.8% | 558 | 527 | 458 | 382 | 396 | 384 | 340 | 324 | 315 | 313 | 320 | 313 | 295 | 290 | 293 | 282 | 285 | 6.00 | 276 | 200 | 8.00 |
Current Liabilities | 0.2% | 1,051 | 1,049 | 914 | 865 | 818 | 881 | 939 | 921 | 955 | 944 | 792 | 683 | 750 | 766 | 646 | 643 | 641 | 633 | 599 | 563 | 532 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 332 | 323 | 225 | 206 |
LT Debt, Non Current | 1.2% | 1,123 | 1,109 | 1,201 | 1,137 | 1,171 | 1,205 | 1,222 | 718 | 721 | 716 | 842 | 828 | 924 | 915 | 813 | 519 | 494 | - | 323 | - | - |
Shareholder's Equity | 2.7% | 1,231 | 1,199 | 1,114 | 937 | 984 | 1,031 | 1,085 | 1,090 | 1,015 | 982 | 974 | 963 | 907 | 925 | 917 | 855 | 870 | 922 | 905 | 817 | 777 |
Retained Earnings | - | - | - | 1,926 | - | - | - | 1,660 | - | - | - | 1,407 | - | - | - | 1,275 | - | - | - | 1,103 | - | - |
Additional Paid-In Capital | - | - | - | 256 | - | - | - | 238 | - | - | - | 216 | - | - | - | 200 | - | - | - | 177 | - | - |
Shares Outstanding | 0.0% | 147 | 147 | 147 | 147 | 148 | 149 | 151 | 152 | 151 | 152 | 152 | 153 | 154 | 154 | 154 | 154 | 156 | 157 | 157 | 156 | 156 |
Minority Interest | 5.4% | 20.00 | 19.00 | 12.00 | 11.00 | 14.00 | 14.00 | 14.00 | 14.00 | 13.00 | 14.00 | 13.00 | 11.00 | 9.00 | 9.00 | 10.00 | 10.00 | 9.00 | 8.00 | 9.00 | 8.00 | 9.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 20.2% | 342 | 284 | 274 | 242 | 196 | 262 | 282 | 347 | 405 | 395 | 332 | 265 | 235 | 234 | 213 | 210 | 185 | 210 | 240 | 211 | 219 |
Share Based Compensation | -15.6% | 22.00 | 26.00 | 28.00 | 28.00 | 27.00 | 21.00 | 17.00 | 17.00 | 17.00 | 17.00 | 16.00 | 10.00 | 10.00 | 10.00 | 10.00 | 13.00 | 13.00 | 12.00 | 11.00 | 11.00 | 11.00 |
Cashflow From Investing | -32.2% | -341 | -258 | -251 | -150 | -141 | -270 | -192 | -172 | -172 | -116 | -192 | -203 | -167 | -232 | -158 | -275 | -292 | -258 | -123 | 77.00 | 154 |
Cashflow From Financing | 30.4% | -159 | -228 | -415 | 25.00 | 105 | 139 | 319 | -159 | -382 | -391 | -161 | 191 | 397 | 500 | 300 | 99.00 | 133 | 78.00 | -112 | -278 | -332 |
Dividend Payments | -0.7% | 30.00 | 30.00 | 30.00 | 28.00 | 27.00 | 26.00 | 24.00 | 24.00 | 24.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | - | - |
Buy Backs | -33.2% | 121 | 181 | 263 | 321 | 248 | 226 | 153 | 140 | 145 | 157 | 123 | 73.00 | 123 | - | 142 | 285 | 400 | - | - | - | - |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Total revenue | $ 681.9 | $ 588.4 | $ 1,367.2 | $ 1,183.4 |
Total cost of revenue | 341.4 | 290.2 | 667.0 | 578.9 |
Gross profit | 340.5 | 298.2 | 700.2 | 604.5 |
Operating expenses: | ||||
Selling, general and administrative | 177.9 | 152.2 | 340.6 | 297.9 |
Research and development | 71.0 | 59.6 | 140.0 | 116.2 |
Other charges, net | 5.4 | 12.5 | 10.7 | 20.0 |
Total operating expenses | 254.3 | 224.3 | 491.3 | 434.1 |
Operating income | 86.2 | 73.9 | 208.9 | 170.4 |
Interest and other income (expense), net | (8.7) | (4.3) | (24.8) | (6.8) |
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries | 77.5 | 69.6 | 184.1 | 163.6 |
Income tax provision | 19.9 | 19.9 | 49.8 | 51.8 |
Equity in income of unconsolidated investees, net of tax | 0.2 | 0.0 | 0.9 | 0.0 |
Consolidated net income | 57.8 | 49.7 | 135.2 | 111.8 |
Net income attributable to noncontrolling interests in consolidated subsidiaries | 0.7 | 0.2 | 1.6 | 0.7 |
Net income attributable to Bruker Corporation | $ 57.1 | $ 49.5 | $ 133.6 | $ 111.1 |
Net income per common share attributable to Bruker Corporation shareholders: | ||||
Basic | $ 0.39 | $ 0.33 | $ 0.91 | $ 0.74 |
Diluted | $ 0.39 | $ 0.33 | $ 0.91 | $ 0.74 |
Weighted average common shares outstanding: | ||||
Basic | 146.8 | 149 | 146.8 | 149.7 |
Diluted | 147.7 | 149.8 | 147.6 | 150.6 |
Comprehensive income | $ 52.9 | $ 15.9 | $ 145.5 | $ 69.1 |
Less: Comprehensive income (loss) attributable to noncontrolling interests | 1.3 | (0.4) | 2.6 | (0.2) |
Less: Comprehensive loss attributable to redeemable noncontrolling interest | (0.3) | (0.5) | (0.3) | (0.7) |
Comprehensive income attributable to Bruker Corporation | 51.9 | 16.8 | 143.2 | 70.0 |
Product | ||||
Total revenue | 559.6 | 485.8 | 1,126.7 | 976.2 |
Total cost of revenue | 272.8 | 230.1 | 530.0 | 459.1 |
Other | ||||
Total revenue | 122.3 | 102.6 | 240.5 | 207.2 |
Total cost of revenue | $ 68.6 | $ 60.1 | $ 137.0 | $ 119.8 |
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 574.8 | $ 645.5 |
Accounts receivable, net | 450.8 | 472.7 |
Inventories | 914.6 | 800.1 |
Assets held for sale | 0.0 | 1.4 |
Other current assets | 243.1 | 193.5 |
Total current assets | 2,183.3 | 2,113.2 |
Property, plant and equipment, net | 522.7 | 487.0 |
Goodwill | 557.9 | 457.6 |
Intangible assets, net | 300.4 | 270.9 |
Other long-term assets | 292.7 | 283.1 |
Total assets | 3,857.0 | 3,611.8 |
Current liabilities: | ||
Current portion of long-term debt | 120.9 | 18.7 |
Accounts payable | 188.8 | 178.4 |
Deferred revenue and customer advances | 397.4 | 370.2 |
Other current liabilities | 343.8 | 347.0 |
Total current liabilities | 1,050.9 | 914.3 |
Long-term debt | 1,122.5 | 1,200.5 |
Other long-term liabilities | 421.0 | 365.2 |
Commitments and contingencies (Note 16) | ||
Redeemable noncontrolling interests | 11.9 | 6.1 |
Shareholders' equity: | ||
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding | 0.0 | 0.0 |
Common stock, $0.01 par value 260,000,000 shares authorized, 175,498,835 and 175,389,586 shares issued and 146,817,075 and 147,023,144 shares outstanding at June 30, 2023 and December 31, 2022, respectively | 1.7 | 1.7 |
Treasury stock, at cost, 28,681,760 and 28,366,442 shares at June 30, 2023 and December 31, 2022, respectively | (1,107.2) | (1,085.0) |
Accumulated other comprehensive income, net of tax | 24.4 | 14.8 |
Other shareholders' equity | 2,312.3 | 2,182.3 |
Total shareholders' equity attributable to Bruker Corporation | 1,231.2 | 1,113.8 |
Noncontrolling interests in consolidated subsidiaries | 19.5 | 11.9 |
Total shareholders' equity | 1,250.7 | 1,125.7 |
Total liabilities, redeemable noncontrolling interests and shareholders' equity | $ 3,857.0 | $ 3,611.8 |